Type 2 Diabetes (T2D)
Summary
Type 2 Diabetes
It originates from insulin resistance and insufficient insulin secretion, typically developing after adulthood. Current treatment methods include dietary control, exercise, and medication therapy; patients with advanced diabetes also need to supplement insulin.
Introduction to T2D
- Disease Characteristics: Type 2 diabetes (T2D) is primarily characterized by hyperglycemia (high blood glucose).
- Pathological Mechanism: Elevated blood sugar results from the body's poor response to insulin (insulin resistance), insufficient insulin secretion, or both occurring simultaneously.
- Preventability: It is potentially preventable and closely linked to lifestyle factors.
- Risk Factors: Lack of physical activity, poor diet, obesity, smoking, as well as genetics and family history.
- Epidemiology: It is much more common than type 1 diabetes, predominantly occurring in adults, but cases in children and young people are also increasing.
Product Development Progress
Scroll left or right to view full progress ➔
Product
(Development Code)
(Development Code)
Indication
Preclinical
Phase 1
Phase 2
Phase 3
PS1
(PS-001)
Type 2 Diabetes
PS1 alone and in combination can treat TD via immune and endocrine modulation
Excess nutrients
PS1 treatment
Market Overview
The global type 2 diabetes (T2D) market size was approximately USD 37.15 billion in 2024 and is projected to reach about USD 76.39 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.47% from 2025 to 2034. This market growth is driven by the rising prevalence of type 2 diabetes, technological advancements, and increasing investment in research and development (R&D).
Type 2 Diabetes Market Size (2024-2034)
Market Value Projection in USD Billion
Value (Billion USD)
90
70
50
30
10
0
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
Source: Precedence Research